Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1W00
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $68,294
Award facts
- Contract value 100% obligated
- $68,293.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $68,293.96 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors, with an ultimate completion date of January 21, 2026. This competitively awarded, firm fixed-price contract includes no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication commonly used to treat moderate-to-severe atopic dermatitis, eosinophilic asthma, and chronic rhinosinusitis with nasal polyps, representing a critical pharmaceutical supply for military healthcare systems.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This comprehensive IDC serves as the primary vehicle for supplying a broad range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs worldwide. AmerisourceBergen's status as a primary vendor in the federal pharmaceutical supply chain and its demonstrated capability to deliver specialty medications make it a key supplier for military treatment facilities and federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26F1W00?
SPE2DR26F1W00 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F1W00 worth?
The government has obligated $68,294 on SPE2DR26F1W00.
Is contract SPE2DR26F1W00 an order under another contract?
Yes. SPE2DR26F1W00 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1W00 competed?
The extent of competition for SPE2DR26F1W00 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award